This test is most useful if any of these apply to you.
If you eat a lot of fish or seafood, some of it may leave more than good fats behind. This test measures a synthetic chemical that fish carry and that your body holds onto for years.
Because this compound barely leaves your body once it arrives, a single reading is a window into your accumulated exposure. Higher levels have been tied most consistently to your cholesterol numbers, with weaker and less consistent links to thyroid hormones and pregnancy outcomes.
PFUnDA (perfluoroundecanoic acid) is one member of a large group of industrial chemicals often called PFAS, or the forever chemicals. It has a chain of 11 carbon atoms wrapped in fluorine, which is exactly what makes it so stable and so slow to break down.
Your body does not make this molecule and has no natural use for it. Every bit found in your blood came from the outside world, mainly through food, and to a lesser degree through contaminated water or transfer from a mother during pregnancy and breastfeeding.
The test measures the concentration circulating in your serum, the liquid part of your blood. This chemical prefers serum over blood cells, so serum is the standard place to look. Because it does not measure any specific organ or process, the number reflects one thing above all: how much of this chemical your body has taken in and stored.
The most repeated finding across human studies is a link to higher cholesterol. This is the signal to pay attention to, because it shows up in different countries, different age groups, and different study designs.
In Norwegian adolescents, higher serum levels of this chemical went along with higher LDL cholesterol (the kind that builds up in arteries), higher total cholesterol, and higher apolipoprotein B (a protein that counts the number of artery-clogging particles). A separate study that followed Norwegian adults with repeated blood samples over 30 years found the same upward pull on total and LDL cholesterol.
A pooled analysis combining many studies reached the same conclusion: people with more of this chemical tended to have modestly higher LDL cholesterol (a small effect, with a pooled estimate of 0.13 and a range of 0.02 to 0.24). One quirk stood out. Triglycerides, another blood fat, tended to run lower rather than higher with this particular compound, unlike the pattern for cholesterol.
What this means for you: if your level here is on the higher side, it is worth pairing this test with a full lipid panel. The two together tell a more useful story than either alone.
The second recurring signal involves thyroid hormones, the chemical messengers that set your metabolic pace. The evidence here is real but more scattered than the cholesterol story.
In a large study of Chinese adults, this compound showed the strongest downward link with the active thyroid hormone T3 among eight PFAS measured. In adolescent boys, higher levels have been tied to shifts in thyroid hormones, though the direction has varied between studies and depended on which hormone was measured: one cohort found lower thyroid hormones, while another found higher free T4. During pregnancy, higher maternal levels have been tied to lower thyroid hormone in both mothers and cord blood. These associations do not prove the chemical causes thyroid disease, but they point to the thyroid as a system worth watching.
This chemical crosses the placenta, though incompletely. In matched mother and newborn pairs, the amount reaching cord blood was about a third of the mother's level (a transfer ratio near 0.36). That partial transfer is enough to matter for early life.
In a birth cohort followed for years, higher levels in cord blood were linked to more common colds by age 2 and more lower respiratory infections through age 10. A separate cohort in Wuhan tied higher prenatal levels to more frequent tonsillitis. The pattern suggests a possible dampening effect on a child's early immune defenses, though this is an association drawn from prenatal exposure, not proof of cause.
Higher levels early in pregnancy have been linked to lower birth weight and to being small for gestational age, an effect seen mainly in girls. Other pregnancy findings are inconsistent. Some analyses point toward higher glucose-related measures, preterm birth, and greater odds of early-onset preeclampsia, though these signals are not consistent across studies. Taken together, the pregnancy evidence is mixed rather than settled.
Some results seem to point the wrong way. In older adults, rising levels of this chemical tracked with better kidney filtration over 10 years, and in women, with slightly lower fasting glucose. It would be a mistake to read these as the chemical being good for you.
This is an exposure indicator rather than a simple good-number or bad-number marker, and exposure interacts with your body in ways that can flip the apparent direction. Kidney function, for example, affects how the chemical is cleared, so people with healthier kidneys can end up with different measured levels for reasons that have nothing to do with benefit. These associations are also non-monotonic, meaning the relationship is not a straight line, and they are hard to separate from the chemical's slow, complex handling by the body. The consistent, harm-leaning signals are the cholesterol and thyroid findings, not these reversed ones.
This chemical has an estimated half-life in humans of about 4.4 years, meaning it takes roughly that long for your body to clear half of what is present. This is an estimate carrying real uncertainty, since most direct half-life data come from other PFAS like PFOA and PFOS. Still, the point holds: this compound leaves the body slowly, and that slowness is exactly why trending matters. A single value tells you your current stored burden, but a series of values tells you whether it is climbing, holding, or slowly falling.
This is a research-grade exposure marker without standardized clinical cutoffs, so no lab can tell you a single safe or unsafe number. That is a reason to establish a baseline now and track it, not a reason to skip it. If you change your exposure, for example by shifting your seafood habits or filtering your water, retest after 6 to 12 months. Because clearance is slow, expect gradual change rather than a fast drop. Annual testing thereafter gives you your own trajectory to work from.
A few factors can distort how you interpret one result:
If your level comes back higher than you expected, the useful next step is to widen the picture rather than fixate on this one number. Order a broader PFAS panel alongside it, since the common members (PFOS, PFOA, PFHxS, and PFNA) tell you whether your exposure is dominated by sulfonate chemicals or by long-chain carboxylates like this one, which cluster with seafood and marine-food sources.
Pair the result with the health systems the evidence points to: a full lipid panel for cholesterol, thyroid hormones if you have symptoms, and kidney filtration for context. Then investigate your likely sources, especially your seafood intake and your drinking water. If your levels are high or you have a known exposure history, a clinician or medical toxicologist can help interpret the pattern and decide what, if anything, warrants action.
Evidence-backed interventions that affect your PFUnDA level
PFUnDA is best interpreted alongside these tests.
PFUnDA is included in these pre-built panels.